From: Schedule-selective biochemical modulation of 5-fluorouracil in advanced colorectal cancer – a phase II study
Total Patients
95
100%
Median Age Years (range)
64 (34–84)
Sex
Female
49
52%
Male
46
48%
Race
African American
21
22%
Caucasian
74
78%
Primary Disease
Colon
82
86%
Rectal
13
14%
Performance Status
0
35
37%
1
52
55%
2
8
8%